2i‘s Principal Scientist, Delwyn Evans, was inter- viewed by Julian Taub for a TechSplurge Blog as part of the Faces of Nano series.
Moreover, P2i has won an International Stevie Award for 2011’s ‘Most Innovative Company in Europe’ at the 2011 International Business Awards (IBAs). Nick- named the Stevie®
for the Greek word “crowned,”
the Awards honor great performance in business globally.
rug delivery company pSivida Corp. (NASDAQ: PSDV; ASX: PVA) has entered into an evalu-
ation agreement with Hospital for Special Surgery (HSS), a world leader in orthopedics, rheumatology and rehabilitation, to investigate pSivida’s drug deli- very technologies in orthopedics.
This agreement follows pSivida’s announcement in June that it has renegotiated its collaboration ag- reement with Pfizer to focus solely on developing a bioerodible sustained release implant for glaucoma and ocular hypertension. (This program is already in clinical trials).
“We believe this orthopedic evaluation agreement is important for pSivida as our drug delivery technolo- gy, originally developed for ophthalmology, is being investigated in broader areas of medicine,” said Dr. Paul Ashton, President and CEO of pSivida. “We are excited to be working with Hospital for Special
© sarastro GmbH s
arastro GmbH recently introduced their novel technology for controlled release of active
agents and substances. These are unique additives Q
ED Technologies International Inc, (QED), has developed a new MRF polishing machine,
the Q22-XE3, which is classified as EAR99 and can be shipped to many countries and destinations under most circumstances without requiring an export license. The Q22-XE3 is designed to polish with the same accuracy as other QED MRF systems, but it employs fewer axes of motion. It can polish many ro- tationally symmetric, convex and concave optics up to 100mm in diameter, but within a narrower range than other QED MRF systems.
Surgery because of their long history of innovation and research in orthopaedic surgery.”
11-08 :: August 2011